107 related articles for article (PubMed ID: 11549245)
21. Thyroid hormone interacts with PPARalpha and PGC-1 during mitochondrial maturation in sheep heart.
McClure TD; Young ME; Taegtmeyer H; Ning XH; Buroker NE; López-Guisa J; Portman MA
Am J Physiol Heart Circ Physiol; 2005 Nov; 289(5):H2258-64. PubMed ID: 16024569
[TBL] [Abstract][Full Text] [Related]
22. Reduced heart size and increased myocardial fuel substrate oxidation in ACC2 mutant mice.
Essop MF; Camp HS; Choi CS; Sharma S; Fryer RM; Reinhart GA; Guthrie PH; Bentebibel A; Gu Z; Shulman GI; Taegtmeyer H; Wakil SJ; Abu-Elheiga L
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H256-65. PubMed ID: 18487439
[TBL] [Abstract][Full Text] [Related]
23. Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle.
Huss JM; Torra IP; Staels B; Giguère V; Kelly DP
Mol Cell Biol; 2004 Oct; 24(20):9079-91. PubMed ID: 15456881
[TBL] [Abstract][Full Text] [Related]
24. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.
Gilde AJ; van der Lee KA; Willemsen PH; Chinetti G; van der Leij FR; van der Vusse GJ; Staels B; van Bilsen M
Circ Res; 2003 Mar; 92(5):518-24. PubMed ID: 12600885
[TBL] [Abstract][Full Text] [Related]
25. Altered Oxygen Utilisation in Rat Left Ventricle and Soleus after 14 Days, but Not 2 Days, of Environmental Hypoxia.
Horscroft JA; Burgess SL; Hu Y; Murray AJ
PLoS One; 2015; 10(9):e0138564. PubMed ID: 26390043
[TBL] [Abstract][Full Text] [Related]
26. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial proteins in hypertrophy and atrophy: a transcript analysis in rat heart.
Taegtmeyer H; Razeghi P; Young ME
Clin Exp Pharmacol Physiol; 2002 Apr; 29(4):346-50. PubMed ID: 11985548
[TBL] [Abstract][Full Text] [Related]
28. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator- activated receptor alpha- deficient mice.
Djouadi F; Weinheimer CJ; Saffitz JE; Pitchford C; Bastin J; Gonzalez FJ; Kelly DP
J Clin Invest; 1998 Sep; 102(6):1083-91. PubMed ID: 9739042
[TBL] [Abstract][Full Text] [Related]
29. Sex difference in hepatic peroxisome proliferator-activated receptor alpha expression: influence of pituitary and gonadal hormones.
Jalouli M; Carlsson L; Améen C; Lindén D; Ljungberg A; Michalik L; Edén S; Wahli W; Oscarsson J
Endocrinology; 2003 Jan; 144(1):101-9. PubMed ID: 12488335
[TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator-activated receptor alpha (PPARalpha) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart.
Finck BN; Kelly DP
J Mol Cell Cardiol; 2002 Oct; 34(10):1249-57. PubMed ID: 12425323
[TBL] [Abstract][Full Text] [Related]
31. Malonyl CoA control of fatty acid oxidation in the newborn heart in response to increased fatty acid supply.
Onay-Besikci A; Sambandam N
Can J Physiol Pharmacol; 2006 Nov; 84(11):1215-22. PubMed ID: 17218986
[TBL] [Abstract][Full Text] [Related]
32. Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) alpha and delta and PPAR coactivator 1alpha in human skeletal muscle, but not lipid regulatory genes.
Watt MJ; Southgate RJ; Holmes AG; Febbraio MA
J Mol Endocrinol; 2004 Oct; 33(2):533-44. PubMed ID: 15525607
[TBL] [Abstract][Full Text] [Related]
33. Alterations of PPARalpha and its coactivator PGC-1 in cisplatin-induced acute renal failure.
Portilla D; Dai G; McClure T; Bates L; Kurten R; Megyesi J; Price P; Li S
Kidney Int; 2002 Oct; 62(4):1208-18. PubMed ID: 12234291
[TBL] [Abstract][Full Text] [Related]
34. Human skeletal muscle PPARalpha expression correlates with fat metabolism gene expression but not BMI or insulin sensitivity.
Zhang J; Phillips DI; Wang C; Byrne CD
Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E168-75. PubMed ID: 14519597
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of peroxisome proliferator-activated receptor-alpha gene expression in a mouse model of ischemic cardiomyopathy is dependent on reactive oxygen species and prevents lipotoxicity.
Dewald O; Sharma S; Adrogue J; Salazar R; Duerr GD; Crapo JD; Entman ML; Taegtmeyer H
Circulation; 2005 Jul; 112(3):407-15. PubMed ID: 16009788
[TBL] [Abstract][Full Text] [Related]
36. Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-alpha dependent.
Barclay TB; Peters JM; Sewer MB; Ferrari L; Gonzalez FJ; Morgan ET
J Pharmacol Exp Ther; 1999 Sep; 290(3):1250-7. PubMed ID: 10454501
[TBL] [Abstract][Full Text] [Related]
37. Control of human carnitine palmitoyltransferase II gene transcription by peroxisome proliferator-activated receptor through a partially conserved peroxisome proliferator-responsive element.
Barrero MJ; Camarero N; Marrero PF; Haro D
Biochem J; 2003 Feb; 369(Pt 3):721-9. PubMed ID: 12408750
[TBL] [Abstract][Full Text] [Related]
38. Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response.
Feingold K; Kim MS; Shigenaga J; Moser A; Grunfeld C
Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E201-7. PubMed ID: 14701665
[TBL] [Abstract][Full Text] [Related]
39. Luteolin improves myocardial cell glucolipid metabolism by inhibiting hypoxia inducible factor-1α expression in angiotensin II/hypoxia-induced hypertrophic H9c2 cells.
Wang J; Gao T; Wang F; Xue J; Ye H; Xie M
Nutr Res; 2019 May; 65():63-70. PubMed ID: 30954346
[TBL] [Abstract][Full Text] [Related]
40. Peroxisome proliferator-activated receptor alpha is involved in the regulation of lipid metabolism by ginseng.
Yoon M; Lee H; Jeong S; Kim JJ; Nicol CJ; Nam KW; Kim M; Cho BG; Oh GT
Br J Pharmacol; 2003 Apr; 138(7):1295-302. PubMed ID: 12711630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]